Array
Array
The new Breast Cancer Prevention Study will focus on vitamin D
A new study aims to analyze the effects of vitamin D in relation to breast cancer rates – specifically, the study centers around investigating the incidence of breast cancer in a population of women 60 and over who achieve and maintain a target serum vitamin D in the bloodstream. In addition to prevention of breast cancer, short-term effects of vitamin D, such as hypertension, falls, colds and flu can also be tracked. At least 1000 women are expected to participate.
Community groups can enroll in this study, unlike previous studies that will examine the results achieved in relation to levels of serum vitamin D rather than a specific dose. Leaders of interest groups in the community want Carole Baggerly, GrassrootsHealth director, Carol (a) grassrootshealth (dot) org for more information.
“We designed this public health study to analyze the role of vitamin D in preventing breast cancer, focusing on women performing a physiological serum vitamin D concentration (40-60 ng / ml) instead give a fixed amount by mouth, “says Robert P. Heaney, MD, Creighton University, a co-investigator of the study.
The study began with a community group in northwest Arkansas, and is sponsored by local individuals and philanthropic groups. Bio-Tech Pharmacal, based in Fayetteville, AR, supplements provide no cost to study participants.
Women in the study should be free of cancer at the time of registration (which may have had in the past). Participation shall include a vitamin D and testing of an online health questionnaire is completed every six months during a period of 5 years.
Based on previously published data, it is estimated that there may be a prevention to 75% of cases of breast cancer. Each year, public health reports published to show the health of the community registered.
The need to try something different in the field of breast cancer research was recently brought home for “Breast Cancer To: Report of the baseline” of the National Breast Cancer Coalition, which recognized that “the results breast cancer that most of the subject have not changed much over the past 20 years. The rate at which women are diagnosed with metastatic disease has remained constant for over 40 years and mortality of the disease has declined lightly. ”
In addition to changing the focus of the dose of vitamin D levels, this study also changes the approach to finding a cure for cancer screening or primary prevention. “Many breast cancer organizations are trying to help women cope with breast cancer, but” primary prevention is virtually unknown, “Baggerly says.” We do not do prevention, “said an organization,” we have to meet patients who have cancer. “According to Baggerly,” No organization can actually prevent the incidence of breast cancer or to reduce repetition without attention to vitamin D. ”
For more information please contact:
Carole Baggerly, 619-823-7062
For more information about the public health issue of vitamin D, please visit http://www.grassrootshealth.net/.
Write a comment
A new study aims to analyze the effects of vitamin D in relation to breast cancer rates – specifically, the study centers around investigating the incidence of breast cancer in a population of women 60 and over who achieve and maintain a target serum vitamin D in the bloodstream. In addition to prevention of breast cancer, short-term effects of vitamin D, such as hypertension, falls, colds and flu can also be tracked. At least 1000 women are expected to participate.
Community groups can enroll in this study, unlike previous studies that will examine the results achieved in relation to levels of serum vitamin D rather than a specific dose. Leaders of interest groups in the community want Carole Baggerly, GrassrootsHealth director, Carol (a) grassrootshealth (dot) org for more information.
“We designed this public health study to analyze the role of vitamin D in preventing breast cancer, focusing on women performing a physiological serum vitamin D concentration (40-60 ng / ml) instead give a fixed amount by mouth, “says Robert P. Heaney, MD, Creighton University, a co-investigator of the study.
The study began with a community group in northwest Arkansas, and is sponsored by local individuals and philanthropic groups. Bio-Tech Pharmacal, based in Fayetteville, AR, supplements provide no cost to study participants.
Women in the study should be free of cancer at the time of registration (which may have had in the past). Participation shall include a vitamin D and testing of an online health questionnaire is completed every six months during a period of 5 years.
Based on previously published data, it is estimated that there may be a prevention to 75% of cases of breast cancer. Each year, public health reports published to show the health of the community registered.
The need to try something different in the field of breast cancer research was recently brought home for “Breast Cancer To: Report of the baseline” of the National Breast Cancer Coalition, which recognized that “the results breast cancer that most of the subject have not changed much over the past 20 years. The rate at which women are diagnosed with metastatic disease has remained constant for over 40 years and mortality of the disease has declined lightly. ”
In addition to changing the focus of the dose of vitamin D levels, this study also changes the approach to finding a cure for cancer screening or primary prevention. “Many breast cancer organizations are trying to help women cope with breast cancer, but” primary prevention is virtually unknown, “Baggerly says.” We do not do prevention, “said an organization,” we have to meet patients who have cancer. “According to Baggerly,” No organization can actually prevent the incidence of breast cancer or to reduce repetition without attention to vitamin D. ”
For more information please contact:
Carole Baggerly, 619-823-7062
For more information about the public health issue of vitamin D, please visit http://www.grassrootshealth.net/.
